LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	AZD7762	0.37	uM	LJP6	72	hr	1657	4158	5383	0.7729	0.7188
BT-20	AZD8055	3.33	uM	LJP6	72	hr	1657	1826	5383	0.3392	0.0581
BT-20	AT-7519	0.04	uM	LJP6	72	hr	1657	5115	5383	0.9511	0.9422
BT-20	AZD7762	0.12	uM	LJP6	72	hr	1657	5352	5383	0.9954	0.9950
BT-20	AZD8055	0.04	uM	LJP6	72	hr	1657	2584	5383	0.4793	0.2957
BT-20	AZD8055	1.11	uM	LJP6	72	hr	1657	1987	5383	0.3688	0.1108
BT-20	Seliciclib	0.37	uM	LJP5	72	hr	1657	5212	5588	0.9328	0.9221
BT-20	Seliciclib	10	uM	LJP5	72	hr	1657	2184	5588	0.3907	0.1692
BT-20	AT-7519	1.11	uM	LJP6	72	hr	1657	1474	5383	0.2737	-0.0680
BT-20	AZD7762	0.04	uM	LJP6	72	hr	1657	5881	5383	1.0932	1.1076
BT-20	AZD7762	3.33	uM	LJP6	72	hr	1657	1552	5383	0.2891	-0.0378
BT-20	AZD7762	10	uM	LJP6	72	hr	1657	836	5383	0.1552	-0.3321
BT-20	AZD8055	0.12	uM	LJP6	72	hr	1657	2341	5383	0.4347	0.2245
BT-20	AZD8055	0.37	uM	LJP6	72	hr	1657	1984	5383	0.3689	0.1117
BT-20	Seliciclib	0.04	uM	LJP5	72	hr	1657	5718	5588	1.0234	1.0266
BT-20	Seliciclib	0.12	uM	LJP5	72	hr	1657	5585	5588	0.9996	0.9994
BT-20	Seliciclib	1.11	uM	LJP5	72	hr	1657	4763	5588	0.8525	0.8258
BT-20	Seliciclib	3.33	uM	LJP5	72	hr	1657	4547	5588	0.8139	0.7783
BT-20	AT-7519	0.12	uM	LJP6	72	hr	1657	4313	5383	0.8018	0.7564
BT-20	AT-7519	0.37	uM	LJP6	72	hr	1657	1889	5383	0.3511	0.0799
BT-20	AT-7519	3.33	uM	LJP6	72	hr	1657	1217	5383	0.2261	-0.1671
BT-20	AT-7519	10	uM	LJP6	72	hr	1657	922	5383	0.1714	-0.2941
BT-20	AZD7762	1.11	uM	LJP6	72	hr	1657	2517	5383	0.4683	0.2793
BT-20	Sorafenib	0.04	uM	LJP6	72	hr	1657	5122	5383	0.9509	0.9397
BT-20	AZD8055	10	uM	LJP6	72	hr	1657	1508	5383	0.2798	-0.0557

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)